{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:11:56Z","timestamp":1780917116245,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K04969"],"award-info":[{"award-number":["23K04969"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bmcl.2025.130445","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:04:02Z","timestamp":1760911442000},"page":"130445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of a novel pharmacokinetic booster: A small intestine-selective CYP3A4 inhibitor with dibenzyl ether structure"],"prefix":"10.1016","volume":"131","author":[{"given":"Shoki","family":"Hoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisaki","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Karuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tarui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Omote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bmcl.2025.130445_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00008571-199410000-00003","article-title":"CYP3A gene expression in human gut epithelium","volume":"4","author":"Kolars","year":"1994","journal-title":"Pharmacogenetics"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130445_bb0010","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1172\/JCI34007","article-title":"Gut instincts: CYP3A4 and intestinal drug metabolism","volume":"117","author":"Thummel","year":"2007","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130445_bb0015","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1172\/JCI33435","article-title":"Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism","volume":"117","author":"van Herwaarden","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130445_bb0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3565(25)12840-1","article-title":"Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes","volume":"277","author":"Kumar","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2025.130445_bb0025","doi-asserted-by":"crossref","unstructured":"Hsu A, Granneman GR, Bertz RJ. Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents. Clin Pharmacokinet. 1998;35(4):275\u2013291. doi:https:\/\/doi.org\/10.2165\/00003088-199835040-00002. Erratum in: Clin Pharmacokinet. 1998 December;35(6):473. PMID: 9812178.","DOI":"10.2165\/00003088-199835040-00002"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130445_bb0030","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.3390\/scipharm86040043","article-title":"Pharmacokinetic enhancers (boosters)\u2014escort for drugs against degrading enzymes and beyond","volume":"86","author":"Krau\u00df","year":"2018","journal-title":"Sci Pharm"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130445_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40780-024-00376-4","article-title":"Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir\/ritonavir: a retrospective observational study","volume":"10","author":"Tomida","year":"2024","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.bmcl.2025.130445_bb0040","first-page":"2227","article-title":"This is safe antedrug concept, see: Khan MOF, Park KK, Lee HJ. Antedrugs: an approach to safer drugs","volume":"12","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2025.130445_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128868","article-title":"Discovery of benzyloxyphenyl- and phenethylphenyl-imidazole derivatives as a new class of ante-drug type boosters","volume":"72","author":"Kawai","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130445_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2024.101005","article-title":"In vitro demonstration of antedrug mechanism of a pharmacokinetic booster to improve CYP3A4 substrates by CYP3A4-mediated metabolism inhibition","volume":"56","author":"Kataoka","year":"2024","journal-title":"Drug Metab Pharmacokinet"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130445_bb0055","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0009-9236(97)90191-0","article-title":"Itraconazole greatly increases plasma concentrations and effects of felodipine","volume":"61","author":"Jalava","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130445_bb0060","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1359-6446(04)03115-0","article-title":"Compound lipophilicity for substrate binding to human P450s in drug metabolism","volume":"9","author":"Lewis","year":"2004","journal-title":"Drug Discov Today"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130445_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312791","article-title":"Determination of CYP450 expression levels in the human small intestine by mass spectrometry-based targeted proteomics","volume":"22","author":"Grangeon","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130445_bb0070","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130445_bb0075","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/(SICI)1096-987X(19970430)18:6<757::AID-JCC3>3.0.CO;2-R","article-title":"Hydrogen bonding of carbonyl, ether, and ester oxygen atoms with alkanol hydroxyl groups","volume":"18","author":"Lommerse","year":"1997","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmcl.2025.130445_or0010","doi-asserted-by":"crossref","unstructured":"The pKaH values of the azoles in H2O are as follows: 1,2,4-triazole, pKaH = 2.19; thiazole, pKaH = 2.51; imidazole, pKaH = 6.95. See: (a)Garratt PJ. 4.02 \u2212 1,2,4-triazoles. In: Katritzky AR, Rees CW, Scriven EFV, eds. Comprehensive Heterocyclic Chemistry II. Pergamon. Elsevier Science Limited; 1996:127-163. doi: https:\/\/doi.org\/10.1016\/B978-008096518-5.00080-0.","DOI":"10.1016\/B978-008096518-5.00080-0"},{"key":"10.1016\/j.bmcl.2025.130445_rf0075","article-title":"Electrical effects in monosubstituted thiazoles. pKa Values of some 5- and 2-substituted thiazoles","volume":"2","author":"Forlani","year":"1979","journal-title":"J Chem Soc Perkin Trans"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130445_rf0080","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/jo01027a023","article-title":"The ionization constants of some imidazoles","volume":"29","author":"Gallo","year":"1964","journal-title":"J Organomet Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130445_bb0085","first-page":"038","article-title":"1-Aminobenzotriazole: a mechanism-based cytochrome P450 inhibitor and probe of cytochrome P450 biology","volume":"8","author":"PRO","year":"2018","journal-title":"Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130445_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2133\/dmpk.21.173","article-title":"Human carboxylesterase isozymes: catalytic properties and rational drug design","volume":"21","author":"Imai","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130445_bb0095","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.106.009381","article-title":"Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine","volume":"34","author":"Imai","year":"2006","journal-title":"Drug Metab Dispos"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:32:56Z","timestamp":1780914776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25003543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":21,"alternative-id":["S0960894X25003543"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130445","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel pharmacokinetic booster: A small intestine-selective CYP3A4 inhibitor with dibenzyl ether structure","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130445"}}